Cambridge Investment Research Advisors’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Cambridge Investment Research Advisors's ALAB Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Astera Labs (ALAB) stake by 27% in Q2 2026, buying an estimated $2.28M and bringing the position to 40,269 shares worth $19.5M. The position accounts for 0.04% of the portfolio, ranked #424.
Cambridge Investment Research Advisors first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Cambridge Investment Research Advisors held 40,269 shares of Astera Labs worth $19.5M as of Q2 2026.
- Cambridge Investment Research Advisors bought 8,606 Astera Labs shares in Q2 2026, an estimated $2.28M.
- Astera Labs made up 0.04% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #424 holding.
- Cambridge Investment Research Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.